Top CFOs is pleased to announce The Top 25 Healthcare Investment Banking Executives of 2022. The ability to effectively advise healthcare companies on financial matters requires highly specific expertise. Through years of navigating challenging deal dynamics, these investment bankers have earned their reputations as being some of the best on Wall Street. Their capabilities cover M&A, equity capital markets, debt capital markets, private markets, restructurings, and other transaction types. They work with all segments of the healthcare industry from healthcare services to life sciences to medical devices and beyond.
Among this year’s awardees is David Kostel, Global Co-Head of Healthcare for Credit Suisse, who has advised on numerous industry-defining transactions including Bayer's $62 billion offer for Monsanto, $20 billion acquisition of Schering AG, and $7.6 billion sale of it’s Animal Health business. Awardee John Collins, Global Head of Healthcare Investment Banking at Morgan Stanley, is a veteran M&A banker having spent nearly three decades in the field, previously serving as the firm’s global COO in the investment banking division. Also awarded is Mark Hanson, Senior Managing Director for Evercore, whose recent transactions include advising athenahealth on its sale to Hellman & Friedman and Bain Capital, and Vocera Communications on its sale to Stryker.
We acknowledge these individuals for their expertise and dedication to their profession. Please join us in celebrating the accomplishments of The Top 25 Healthcare Investment Banking Executives of 2022.
1. David Gluckman
Vice Chairman of Investment Banking & Global Head of Healthcare, Lazard
David Gluckman is Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. He joined the firm in 1998 and provides strategic and financial advice to senior executives and boards of directors at leading healthcare companies globally. He is a member of Lazard’s Global Executive Committee, North American Marketing Committee and Fairness Opinion Committee.
Gluckman is a member of the advisory board of the Vagelos Program in Life Sciences and Management, jointly administered by the College of Arts and Sciences and the Wharton School at the University of Pennsylvania. He is a member of the Board of Trustees of the Hackley School. Gluckman is also a member of the Leadership Council of AmeriCares, and is a Lazard representative in The Council of Foreign Relations, Corporate Leader Program. He is a board member at X-37, LLC, an artificial intelligence-enabled drug discovery company. Gluckman is a licentiate of the Medical Council of Canada and a member of the College of Physicians and Surgeons of Ontario. He graduated from the University of Toronto with an MD and from The Wharton School with an MBA.
2. John Collins
Global Head of Healthcare Investment Banking, Morgan Stanley
John Collins is the Global Head of Healthcare Investment Banking at Morgan Stanley. He first joined the company in 1990 as an analyst of real estate investment banking and was promoted to managing director in 2004. Morgan Stanley mobilizes capital to help governments, corporations, institutions and individuals around the world achieve their financial goals. For over 85 years, the firm’s reputation for using innovative thinking to solve complex problems has been well-earned and rarely matched. The organization is a consistent industry leader throughout decades of dramatic change in modern finance.
Previously, Collins was a managing director at Moelis & Company. He earned an MBA from Stanford University and an undergraduate degree in economics from Dartmouth College.
3. David Kostel
Global Head of Healthcare Investment Banking, Credit Suisse
David Kostel is a Managing Director of Credit Suisse and Global Co-Head of Healthcare in the Investment Banking Division. He is based in New York and is a member of the Global Operating Committee and Investment Banking Advisory Committee. Kostel previously served as Head of Healthcare M&A, advising on a variety of M&A assignments in transactions valued at over $400 billion. He has 20 years of investment banking experience
Prior to joining Credit Suisse in 2000, Kostel worked in Stern Stewart & Co.'s Corporate Financial Advisory Group, focusing on mergers and acquisitions and financial strategy. He earned a JD and MBA, as well as an undergraduate degree in economics from the University of Virginia.
4. Jim Sinclair
Managing Director of Healthcare Investment Banking, Goldman Sachs
Jim Sinclair is a Managing Director of Healthcare Investment Banking at Goldman Sachs. Sinclair’s responsibilities cover healthcare services and technology companies. Headquartered in New York, Goldman Sachs is a leading global investment banking, securities and investment management firm.
Previously, Sinclair was a healthcare services equity research analyst. He first joined Goldman Sachs in 2002 as an analyst and rejoined the firm in 2007 as an associate. He was named vice president in 2010 and managing director in 2015. Sinclair serves as a member of the advisory board for Ben’s Friends, a nonprofit focused on building online communities for patients with rare diseases. He earned an undergraduate degree in economics, magna cum laude, from Duke University, a JD from Northwestern University School of Law, and an MBA from the Kellogg School of Management at Northwestern University.
View the complete list of awardees.
5. Helen Oesch
Managing Director of Healthcare Investment Banking, Deutsche Bank
Helen Oesch is a Managing Director of Healthcare Investment Banking with Deutsche Bank. She is a well-known banking veteran and previously served as a director at Credit Suisse for nearly eight years. Oesch was hired on with Deutsche Bank for her expertise and experience, strengthening their existing presence in the U.S. Healthcare Services & Technology sector.
Previously, Oesch was a managing director at BMO Capital Markets. Earlier in her career she worked with Merrill Lynch as an analyst. Oesch earned an undergraduate degree in business administration from the University of St. Gallen.
7. James Hocking
Partner, PwC Australia
James Hocking is a Partner in PwC’s Corporate Advisory practice in Australia and leads their market-leading healthcare and financial sponsor teams. James also serves as the PwC Deals leader in Sydney and as Partner sponsor for the PwC Graduate recruitment program known as the Edge. He has over 20 years experience advising corporates, family offices and financial sponsors on over $65 billion of completed public market and private treaty transactions including acquisitions, IPOs, sales/divestitures, capital raisings and strategic reviews. He has worked on a number of Australia's most iconic and complex healthcare transactions as well as transactions across consumer, industrials, financial services and infrastructure.
An investment banking veteran, James joined PwC in 2018 from Credit Suisse where he was head of the healthcare and financial sponsor investment banking teams in Australia. Prior to this he worked at UBS in their M&A team in Sydney, Melbourne and New York. James holds a Bachelors in Commerce (degree with Honours), specialising in Financial Economics, a Bachelors of Arts (Japanese) from the University of Melbourne and is a Fellow of FINSIA.
11. Wolfgang Wybranietz
Managing Director of M&A & Head of Healthcare, Chemicals, DZ BANK
Wolfgang Wybranietz is a Managing Director of M&A and Head of Healthcare & Chemicals for DZ BANK. DZ BANK is the second-largest commercial bank in Germany and the central institution in the Volksbanken Raiffeisenbanken cooperative financial network. Wybranietz first joined the team in 2001 and has since been part of the Frankfurt team of the Corporate Finance and M&A Department. He is responsible for the healthcare (pharmaceutical, biotech, medtech, hospitals, nursing homes), chemical and agricultural industries and has successfully advised a large number of clients over the last 20 years.
Before joining DZ BANK, Wybranietz worked in basic medical research and spent 6 years working with virus vectors in the treatment of liver cancer. He received his diploma in biochemistry from the University of Tübingen and subsequently completed his doctorate at the Medical University Hospital Tübingen. During his studies Wybranietz spent one year in San Francisco and Berkeley and during his doctoral thesis at the Marie Curie Institute in England.
14. Sonia Gupta
Managing Director of Healthcare Investment Banking, Goldman Sachs
Sonia Gupta is a Managing Director of Healthcare Investment Banking for Goldman Sachs. Goldman Sachs provides investment banking, securities, and investment management services, as well as financial services to corporations, financial institutions, governments, and high-net-worth individuals worldwide. Its Investment Banking segment offers financial advisory services, including advisory assignments with respect to mergers and acquisitions, divestitures, corporate defense, risk management, and restructurings and spin-offs; and underwriting services comprising public offerings and private placements of a range of securities, loans and other financial instruments, and derivative transactions. Gupta has 15 years of experience. She began her career in 2007.
Before joining Goldman Sachs, Gupta was a senior analyst and consultant at Health Advances. She graduated from MIT Sloan School of Management with an MBA and from Brown University with an undergraduate degree in community health.
15. Mark Hanson
Senior Managing Director, Evercore
Mark Hanson is a Senior Managing Director in Evercore’s corporate advisory business. He first joined Evercore in 2014 and has more than 25 years of experience advising companies in the healthcare and technology sectors. He has advised companies across all healthcare sectors and has extensive experience in technology, services, and life sciences tools & diagnostics.
For the 10 years prior to joining Evercore, Hanson was a managing director at Barclays and Lehman Brothers, leading the life sciences tools and healthcare services team. He began his career at Merrill Lynch. Hanson earned an undergraduate degree in economics and mathematics from St. Olaf College and an MBA from the Tuck School at Dartmouth College.
View the complete list of awardees.
17. Adam Berger
Managing Director & Head of Healthcare M&A, Wells Fargo
Adam Berger began his professional career 33 years ago. Today, he is the Managing Director and Head of Healthcare M&A of Wells Fargo, the diversified, community-based financial services company with approximately $1.9 trillion in assets. Berger has been with Wells Fargo since 2011 and is known for his high caliber and efforts in the areas of healthcare, consumer, and retail. His extensive relationships and industry knowledge help the organization strategically expand their capabilities to greatly enhance their ability to help customers succeed financially in critical sectors
Berger first got his start in 1989 as an analyst at Janney Montgomery Scott. From there, he went on to Salomon Brothers before eventually rising to become a managing director and head of M&A at Leerink, his most recent position prior to joining Wells Fargo. Berger graduated from The Wharton School with an undergraduate degree in economics and finance and from the University of Pennsylvania with an undergraduate degree in history and mathematics.
18. Charles Hamilton
Managing Director of Healthcare Investment Banking, Piper Sandler
Charles Hamilton is a Managing Director within the Piper Sandler healthcare group and a Senior Partner of the Medical Technology Team. Hamilton advises clients across a full range of investment banking services, including sell-side, buy-side and cross-border M&A, corporate carve-outs, public and private equity and debt financings, capital allocation and defensive advisory. He has 20 years of healthcare investment banking and capital markets experience, and has completed over 80 M&A and capital markets transactions on behalf of his medical technology clients at Piper Sandler.
Before joining Piper Sandler, Hamilton worked in capital markets advisory at Thomson Financial and before that, he was an options trader at Option Insight Trading LLC. Hamilton graduated from The University of Chicago Booth School of Business with an MBA in analytic finance and accounting and from the University of Chicago with an undergraduate degree in cell and molecular biology.
21. Matt Ryan
Managing Director of Healthcare Group, Houlihan Lokey
Matt Ryan is a Managing Director of the Healthcare Group of Houlihan Lokey, a global investment bank with expertise in M&As, capital markets, financial restructuring, and financial and valuation advisory. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, the Middle East, and the Asia-Pacific region. Ryan has 24 years of experience. He began his career in 1998.
Before joining Houlihan Lokey, Ryan was a senior associate at Casas, Benjamin and White, LLC, and before that a senior associate for transaction services at PricewaterhouseCoopers. Ryan graduated from Michigan State University with an undergraduate degree.
22. Jeffrey Kirshner
Managing Director of Healthcare Services Investment Banking, Guggenheim
Jeffrey Kirshner is a Managing Director of Healthcare Services Investment Banking for Guggenheim. He first joined the company in 2018. Guggenheim Partners is a global investment and advisory firm with more than $300 billion in assets under management. They have a track record of delivering results through innovative solutions across their three primary businesses of investment management, investment banking, and insurance services.
Previously, Kirshner was a VP and associate of investment banking at Jefferies and before that, an investment banking associate and analyst at Duff and Phelps. Kirshner earned an undergraduate degree in finance from the University of Illinois System.
24. Roman Makovitskiy
Managing Director, Healthcare, BofA Securities
Roman Makovitskiy is a Managing Director focused on the Healthcare Services sector at BofA Securities, with deep expertise in Animal Health and Multi-Site Healthcare. Roman has spent 15 years at BofA Securities, and over 20 in the healthcare industry. He has a broad range of M&A and Capital Markets transaction experience for healthcare clients. Most recently Roman was a senior member of the firm’s Healthcare M&A team where he executed 50+ M&A transactions for over $125bn in value.
Prior to joining BofA Securities, Roman was a management consultant focused on the life-sciences sector with Capgemini. Roman graduated from UC Berkeley with a degree in economics and business, and received his MBA from the UCLA Anderson School of Management.
View the complete list of awardees.